Physician profile
Anne Stachowicz
NPI 1467867119
$9,662.41
in general payments reported to CMS, 2019-2025
11 companies · $8,119 in 2025
The $8,119 reported for 2025 was more than what 93% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $39.00 · 2021: $186 · 2022: $526 · 2023: $228 · 2024: $66.33 · 2025: $8,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $3,112 · Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $3,111.61 |
| Food and Beverage | $801.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,362.76 | 2025 | |
| Boston Scientific Corporation | $1,942.07 | 2019-2025 | General - Therapies, Axonics |
| Axonics, INC. | $651.94 | 2020-2024 | Axonics |
| Medtronic, INC. | $173.48 | 2022-2023 | Interstim |
| Medtronic USA, INC. | $161.31 | 2019 | |
| Coloplast Corp | $139.77 | 2019 | |
| Astellas Pharma US INC | $79.97 | 2021-2022 | |
| Urovant Sciences INC | $74.83 | 2022 | |
| Abbvie INC. | $33.04 | 2024 | |
| Caldera Medical, INC | $32.41 | 2022 | |
| Merck Sharp & Dohme LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Stachowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.